Sun Pharma Advanced Research Company Limited (SPARC) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.336x

Based on the latest financial reports, Sun Pharma Advanced Research Company Limited (SPARC) has a cash flow conversion efficiency ratio of 0.336x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-1.16 Billion ≈ $-12.53 Million USD) by net assets (Rs-3.45 Billion ≈ $-37.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SPARC equity to assets ratio to measure how much of total assets are equity-financed.

Sun Pharma Advanced Research Company Limited - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Sun Pharma Advanced Research Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Sun Pharma Advanced Research Company Lim (SPARC) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Sun Pharma Advanced Research Company Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sun Pharma Advanced Research Company Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Lectra SA PA:LSS	0.066x
Shanghai Golden Union Commercial Management Co Ltd SHG:603682	0.144x
Africa Israel Residences Ltd TA:AFRE	-0.033x
Shandong Huatai Paper Industry Shareholding Co Ltd SHG:600308	0.023x
Tropicana Corporation Bhd KLSE:5401	-0.023x
Andlauer Healthcare Gr TO:AND	0.157x
Great Southern Bancorp Inc NASDAQ:GSBC	0.009x
Xuchang Yuandong Drive Shaft Co Ltd SHE:002406	0.015x

Annual Cash Flow Conversion Efficiency for Sun Pharma Advanced Research Company Limited (2007–2025)

The table below shows the annual cash flow conversion efficiency of Sun Pharma Advanced Research Company Limited from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Sun Pharma Advanced Research Company Lim market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs-2.17 Billion ≈ $-23.46 Million	Rs-3.60 Billion ≈ $-38.96 Million	1.661x	+148.66%
2024-03-31	Rs1.26 Billion ≈ $13.60 Million	Rs-4.29 Billion ≈ $-46.42 Million	-3.413x	-2431.86%
2023-03-31	Rs5.13 Billion ≈ $55.45 Million	Rs-691.20 Million ≈ $-7.48 Million	-0.135x	+97.98%
2022-03-31	Rs312.26 Million ≈ $3.38 Million	Rs-2.08 Billion ≈ $-22.52 Million	-6.669x	-838.67%
2021-03-31	Rs-1.68 Billion ≈ $-18.20 Million	Rs-1.52 Billion ≈ $-16.43 Million	0.903x	-92.02%
2020-03-31	Rs-186.38 Million ≈ $-2.02 Million	Rs-2.11 Billion ≈ $-22.80 Million	11.310x	+2048.94%
2019-03-31	Rs2.96 Billion ≈ $32.04 Million	Rs-1.72 Billion ≈ $-18.59 Million	-0.580x	+41.35%
2018-03-31	Rs1.85 Billion ≈ $19.98 Million	Rs-1.83 Billion ≈ $-19.77 Million	-0.989x	-23.37%
2017-03-31	Rs1.60 Billion ≈ $17.27 Million	Rs-1.28 Billion ≈ $-13.85 Million	-0.802x	+45.76%
2016-03-31	Rs299.03 Million ≈ $3.23 Million	Rs-442.12 Million ≈ $-4.78 Million	-1.479x	-272.84%
2015-03-31	Rs997.99 Million ≈ $10.79 Million	Rs-395.76 Million ≈ $-4.28 Million	-0.397x	-249.72%
2014-03-31	Rs1.39 Billion ≈ $15.06 Million	Rs368.95 Million ≈ $3.99 Million	0.265x	+130.12%
2013-03-31	Rs1.08 Billion ≈ $11.73 Million	Rs-953.44 Million ≈ $-10.31 Million	-0.879x	-184.34%
2012-03-31	Rs-666.09 Million ≈ $-7.20 Million	Rs-694.49 Million ≈ $-7.51 Million	1.043x	+134.07%
2011-03-31	Rs56.23 Million ≈ $608.16K	Rs25.05 Million ≈ $270.90K	0.445x	-50.20%
2010-03-31	Rs141.24 Million ≈ $1.53 Million	Rs126.34 Million ≈ $1.37 Million	0.895x	+25.38%
2009-03-31	Rs356.78 Million ≈ $3.86 Million	Rs254.54 Million ≈ $2.75 Million	0.713x	+256.80%
2008-03-31	Rs448.18 Million ≈ $4.85 Million	Rs-203.92 Million ≈ $-2.21 Million	-0.455x	-54787.50%
2007-03-31	Rs497.01 Million ≈ $5.37 Million	Rs-412.00K ≈ $-4.46K	-0.001x	--

About Sun Pharma Advanced Research Company Limited

NSE:SPARC India Drug Manufacturers - Specialty & Generic

Market Cap

$729.75 Million

Rs67.48 Billion INR

Market Cap Rank

#10192 Global

#518 in India

Share Price

Rs207.93

Change (1 day)

+0.83%

52-Week Range

Rs108.71 - Rs277.57

All Time High

Rs519.35